The Quantitative Decision-making Special Interest Group (QDM SIG) was formed in October 2017. It is a group of statisticians from industry and academia, with experience and interests in statistical methods for quantitative decision-making in drug development. The objectives of the SIG are:

  • To share (anonymized) case studies of how quantitative decision-making methods have been used within pharmaceutical companies, for decisions at the trial level, at the development level and at the portfolio level
  • To perform literature reviews, discuss and make recommendations on existing methodologies in terms of approach and interpretation
  • To develop new methodologies or practices where needed
  • To promote the role of the statistician in supporting decision-making in pharmaceutical companies and/or other stakeholders
  • To propose trainings, public meetings or publications to share methods and experience

For further information, or to join the QDM SIG, please contact the co-chairs:

Pierre Colin (Sanofi)
pierre.colin@sanofi.com

and

Gaelle Saint-Hilary (Politecnico di Torino)
gsainthilary@gmail.com

Latest News


Show all news

EventsFuture Events


logo_horizontal_large

Principal Biostatistician

read more...

Astrazeneca

Head, Statistical Modelling & Simulation Services

read more...